Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015
(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 01/28/15 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients'' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, announced today that its fourth quarter 2014 financial results will be released on Friday, February 27, 2015. Following the announcement, Horizon''s management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company''s financial and operating results and provide a general business update.
The live webcast and a replay may be accessed by visiting Horizon''s website at . Please connect to the Company''s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 71462620. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 71462620.
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients'' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. Horizon''s U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon''s global headquarters are in Dublin, Ireland. For more information, please visit .
Robert F. Carey
Executive Vice President, Chief Business Officer
+1 224-383-3250
Geoff Curtis
+1 312-233-1253
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.01.2015 - 07:00 Uhr
Sprache: Deutsch
News-ID 1333139
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
DUBLIN, IRELAND
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 193 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015
"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
